Serotonin Syndrome

Suspect serotonin syndrome in a patient with recent serotonergic medication use who develops a mixed syndrome of mental-status change, autonomic instability, neuromuscular abnormalities, and gastrointestinal symptoms. Reported manifestations include agitation, hallucinations, delirium or coma; tachycardia, labile blood pressure, diaphoresis, flushing, and hyperthermia; tremor, myoclonus, hyperreflexia, incoordination, and rigidity; plus nausea, vomiting, or diarrhea.fda+1fdaFDA warns about several safety issues with opioid pain ...dailymed nlm nihCITALOPRAM

Establish the timeline before assigning an alternative diagnosis. Symptoms generally begin within several hours to a few days after concomitant serotonergic exposure, although later presentation can occur, particularly after a dose increase.fda+2fdaFDA warns about several safety issues with opioid pain ...dailymed nlm nihULTIVAdailymed nlm nihCITALOPRAM A compatible exposure history is central because diagnosis remains clinical and depends on a high index of suspicion rather than a single confirmatory test.NEJM+1NEJMThe Serotonin SyndromeWolters KluwerSerotonin syndrome presenting as hypotonic coma...

Escalate immediately to a monitored medical ward, high-dependency unit, or ICU when severe toxicity is suspected. Hyperthermia with shock, coma, or severe neuromuscular findings signals a potentially fatal emergency rather than uncomplicated medication intolerance.Wiley+1WileyRecognition and mangement of serotonin syndromeWileyCommunicating adverse drug events: serotonin toxicity

SSRIs can cause serotonin syndrome alone, but risk increases when they are combined with other serotonergic drugs or medicines that impair serotonin metabolism. Listed interacting categories include triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, meperidine, methadone, tryptophan, buspirone, amphetamines, St. John’s wort, and monoamine oxidase inhibitors.dailymed nlm nihdailymed nlm nihCITALOPRAM

Do not limit the review to outpatient psychiatric drugs. FDA warns that opioid analgesics can cause serotonin syndrome during concomitant use with serotonergic medicines, including at recommended doses.fdafdaFDA warns about several safety issues with opioid pain ... Remifentanil and sufentanil labeling likewise warns of serotonin syndrome during use with serotonergic drugs and directs discontinuation if the syndrome is suspected.dailymed nlm nih+2dailymed nlm nihULTIVAdailymed nlm nihsufentanil citrate injection Akorndailymed nlm nihsufentanil citrate injection, solution Hospira, Inc.

In perioperative and inpatient cases, reconcile anesthetic and analgesic records, medication-administration times, and newly initiated antimicrobial therapy. Linezolid exposure with an antidepressant is a clinically important interaction scenario, although a cohort study specifically evaluated the incidence of serotonin syndrome in this population rather than establishing that every coexposure requires the same response.JAMAJAMALinezolid and Risk of Serotonin Syndrome in Patients ...

A compatible serotonergic exposure plus the characteristic neuromuscular and autonomic pattern supports the diagnosis, but altered mental status, fever, and abnormal movements are not specific. Keep alcohol withdrawal, a postictal state, anticholinergic toxicity, and other medication-related syndromes in the differential when the history or examination does not fit a serotonergic exposure pattern.BMJ+1BMJSerotonin syndrome caused by drug to drug interaction ...WileyMultiple drug interactions – induced serotonin syndrome

Distinguish a toxicity syndrome from isolated adverse effects by looking for findings across organ systems rather than relying on nausea, anxiety, tremor, or tachycardia alone. The FDA-described syndrome combines mental-status changes, autonomic instability, and neurologic abnormalities; gastrointestinal symptoms may accompany the syndrome but should not drive the diagnosis by themselves.fda+1fdaFDA warns about several safety issues with opioid pain ...dailymed nlm nihCITALOPRAM

Direct testing toward immediate threats and mimics: bedside glucose in altered mental status; ECG when tachycardia, instability, coingestants, or medication effects raise concern; and targeted evaluation for seizure, infection, metabolic derangement, or toxic coexposure when the presentation is atypical. These studies identify competing pathology and organ injury; they do not replace the exposure-linked clinical diagnosis.NEJM+2NEJMThe Serotonin SyndromeWolters KluwerSerotonin syndrome presenting as hypotonic coma...WileyMultiple drug interactions – induced serotonin syndrome

Immediately discontinue suspected causative serotonergic agents. This is explicit in FDA opioid safety communication and in remifentanil and sufentanil labeling; contemporary management reviews prioritize cessation, supportive care, and symptomatic treatment.fda+5fdaFDA warns about several safety issues with opioid pain ...dailymed nlm nihULTIVAdailymed nlm nihsufentanil citrate injection Akorndailymed nlm nihsufentanil citrate injection, solution Hospira, Inc.WileyManagement of serotonin syndrome (toxicity)WileyManagement of serotonin syndrome (toxicity) - Chiew - 2025

Provide symptom-directed supportive care with continuous reassessment of airway, ventilation, oxygenation, circulation, temperature, agitation, and neuromuscular activity. Severe toxicity requires management in an appropriately monitored medical ward, high-dependency unit, or ICU setting.Wiley+2WileyManagement of serotonin syndrome (toxicity)WileyManagement of serotonin syndrome (toxicity) - Chiew - 2025WileyRecognition and mangement of serotonin syndrome

Do not mistake serotonin syndrome for an adverse event that can be observed without intervention when severe findings are present. Hyperthermia, shock, and coma are associated with the severe, potentially fatal form of toxicity; urgent escalation is warranted while supportive measures are underway.Wiley+1WileyRecognition and mangement of serotonin syndromeWileyCommunicating adverse drug events: serotonin toxicity

Cyproheptadine has been evaluated as a treatment for serotonin toxicity, including in a systematic review of deliberate self-poisoning, but the retrieved evidence does not establish a regimen suitable for universal protocolized use.WileyWileyEfficacy of cyproheptadine in the management of serotonin ... In practice, do not delay withdrawal of causative drugs, monitoring, or organ-supportive treatment while considering adjunctive pharmacotherapy.Wiley+2WileyManagement of serotonin syndrome (toxicity)WileyManagement of serotonin syndrome (toxicity) - Chiew - 2025WileyEfficacy of cyproheptadine in the management of serotonin ...

Continue serial reassessment after drug discontinuation because onset may occur within hours to days and may occur later after dose escalation.fda+2fdaFDA warns about several safety issues with opioid pain ...dailymed nlm nihULTIVAdailymed nlm nihCITALOPRAM Track mental status, temperature, heart rate, blood pressure, and neuromuscular findings; worsening rigidity, hyperthermia, labile blood pressure, or declining consciousness should trigger escalation of care.fda+2fdaFDA warns about several safety issues with opioid pain ...dailymed nlm nihCITALOPRAMWileyRecognition and mangement of serotonin syndrome

Before discharge or transfer, reconcile all serotonergic prescriptions, over-the-counter products, supplements, procedural analgesics, and planned postoperative medications. Patients receiving an opioid with serotonergic medication should be counseled to seek urgent care for agitation, hallucinations, tachycardia, fever, sweating, shivering, muscle twitching or stiffness, incoordination, nausea, vomiting, or diarrhea.fda+1fdaFDA warns about several safety issues with opioid pain ...dailymed nlm nihsufentanil citrate injection, solution Hospira, Inc.

For patients who need ongoing antidepressant or analgesic therapy, document the suspected precipitating combination, the temporal relationship, and the severity of the episode. A future prescriber can then select therapy with the prior interaction and any planned opioid or linezolid exposure explicitly considered.fda+2fdaFDA warns about several safety issues with opioid pain ...dailymed nlm nihCITALOPRAMJAMALinezolid and Risk of Serotonin Syndrome in Patients ...